Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Bionovate Technologies Corp.    BIIO

BIONOVATE TECHNOLOGIES CORP.

(BIIO)
  Report
Delayed Quote. Delayed OTC Bulletin Board - Other OTC - 01/27 03:59:23 pm
15 USD   +3.45%
2020Bionovate Announces Return of Shares to Treasury
GL
2020Bionovate seeks to invest in Health and Life Care Startups
GL
2020BIONOVATE REALIGNS ITS STRATEGY : from Quantify Yourself to Know Yourself
AQ
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Bionovate realigns its strategy: from Quantify Yourself to Know Yourself

11/27/2020 | 09:46am EST

CHAM, Switzerland, Nov. 27, 2020 (GLOBE NEWSWIRE) -- The medical device company Bionovate Technologies Corp adopts a strategic reorientation under new management. Aleksandar Vucak will realign the company as CEO after taking over the majority of the shares of the company, traded on the Nasdaq OTC (OTCPK:BIIO). 

Bionovate Technologies Corp. will focus on investments and the marketing of patents and licenses which bring healthcare and lifestyle diagnostics to the smartphone. With strong emphasis on digital transformation, the company intends to build an FDA-approved ecosystem of medical devices, biosensors and mobile applications to turn tests that were previously only done in physical labs into tests that can be carried through by anyone with a mobile device. Innovations in these fields are transforming some of the most promising, high-growth-opportunity segments in the medical device market worldwide. 

To this end, new products and services will be developed in the coming months on the basis of existing patents. The focus will be on the acquisition of medical data from non-invasive sources (e.g. ultrasound, impedance measurements, motion profiles, other visualisation procedures) and their direct connection to mighty Big Data platforms, which use machine learning and artificial intelligence to provide the data as simple and clear as possible for the end user. With these new methods of wearable biosensing, which go far beyond the signals recorded so far, health-conscious and sporty consumers can measure and implement their fitness and health goals much better. 

CEO Aleksandar Vucak: "A wide range of applications and digital services in the lifestyle and medical care sectors are possible here. The entire wearables market is facing major disruptions because much more wearable biosensing is finally becoming possible. Completely new methods of signal processing and innovative digital communication architectures.  We are just crossing the threshold from ‘Quantify Yourself’ to ‘Know Yourself’. In this wave of innovation that is about to hit the market, we want to make a contribution to ensuring that many people live more health-consciously, listen to their body's warning signals early on and thus live better."

Bionovate Technologies Corp.
Gewerbestr. 10
6330 Cham
Switzerland

Press contact:
Sandra Meyer
Tel: +41 581 01 02 02
Mail: press@bionovate.com

 



© GlobeNewswire 2020
All news about BIONOVATE TECHNOLOGIES CORP.
2020Bionovate Announces Return of Shares to Treasury
GL
2020Bionovate seeks to invest in Health and Life Care Startups
GL
2020BIONOVATE REALIGNS ITS STRATEGY : from Quantify Yourself to Know Yourself
AQ
2020BIONOVATE REALIGNS ITS STRATEGY : from Quantify Yourself to Know Yourself
GL
2020BIONOVATE TECHNOLOGIES : Management's Discussion and Analysis of Financial Condi..
AQ
2020BIONOVATE TECHNOLOGIES : Entry into a Material Definitive Agreement, Financial S..
AQ
2020BIONOVATE TECHNOLOGIES : Regarding Share Transfere AGreement Human Data - Evergr..
AQ
2020BIONOVATE TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
2020BIONOVATE TECHNOLOGIES : picks up semanticom for international PR
AQ
2020Bionovate Technologies picks up semanticom for international PR
GL
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 -0,12 M - -
Net Debt 2020 0,23 M - -
P/E ratio 2020 -205x
Yield 2020 -
Capitalization 684 M 684 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees -
Free-Float 8,67%
Chart BIONOVATE TECHNOLOGIES CORP.
Duration : Period :
Bionovate Technologies Corp. Technical Analysis Chart | BIIO | US09074V2025 | MarketScreener
Income Statement Evolution
Managers and Directors
NameTitle
Aleksandar Vucak President, CEO, CFO, Secretary & Director
Sector and Competitors
1st jan.Capitalization (M$)
BIONOVATE TECHNOLOGIES CORP.-23.72%661
CK HUTCHISON HOLDINGS LIMITED1.48%27 482
INDUSTRIVÄRDEN AB5.47%14 903
KINNEVIK AB3.01%14 385
LIFCO AB (PUBL)1.20%8 745
SOMFY SA9.67%6 356